Evaluation of Methotrexate-Loaded Surfactants, Ceramides, and Cholesterol-Based Lamellar Phases as a Topical Treatment for Psoriasis
February 2022
in “
Journal of Pharmacy and Pharmacology
”
TLDR Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.
The study evaluated methotrexate-loaded surfactants, ceramides, and cholesterol-based lamellar phases as a topical treatment for psoriasis using a mouse model. The formulations, C1CH and C1CHCE, showed significant immunomodulatory effects, such as increased epidermal thickness and inflammatory cytokine levels, but did not outperform dexamethasone in reducing psoriasiform dermatitis symptoms. The study concluded that while these formulations could potentially enhance methotrexate delivery, they induced inflammation and worsened skin conditions, highlighting the need for careful evaluation of liquid crystals as topical drug delivery systems for psoriasis. The number of participants was not specified, limiting the assessment of the study's strength.